is serena williams really on glp 1 EXCLUSIVE: has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an exclusive TODAY interview., The 23-time Grand Slam champion Serena Williams Opens Up About

Your genetic peptide profile helps determine which path makes sense

Drug interaction considerations Semaglutide interactions are the same regardless of the source

User experimentation suggests that longer initial treatment periods (6+ months continuous) support better benefit retention during subsequent breaks, complete discontinuation breaks of 1-2 months show acceptable benefit maintenance for most users, and very extended breaks (3-6+ months) increase risk of regression toward pre-treatment baseline particularly for short initial treatment courses

Kirkpatrick A, Heo J, Abrol R, Goddard WA: Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor

Water retention tends to be dose dependent